Annual screening beneficial in high-risk PCa patients


Annual PSA screening yields a greater quality-adjusted life expectancy among patients who have a high risk of developing metastatic disease in comparison to unscreened patients, according to a recent study.

Related Videos
Samuel L. Washington III, MD, answers a question during a Zoom video interview
blurred image of a clinic hallway
Dr. Kyle A. Richards in an interview with Urology Times
Expert on OAB
Experts on OAB
Expert on OAB
3d rendered illustration - bladder cancer | Image Credit: © SciePro -
stethoscope on laptop keyboard
Related Content
© 2023 MJH Life Sciences

All rights reserved.